Puzo Michael J Novartis Ag Transaction History

Puzo Michael J

$375 Million
Q3 2024

A detailed history of Puzo Michael J transactions in Novartis Ag stock. As of the latest transaction made, Puzo Michael J holds 7,325 shares of NVS stock, worth $725,907. This represents 0.22% of its overall portfolio holdings.

Number of Shares

7,325

Previous 13,145 44.28%

Holding current value

$725,907

Previous $1.4 Million 39.81%

% of portfolio

0.22%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $617,676 - $703,579	-5,820 Reduced 44.28%	7,325 $842,000
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $2.01 Million - $2.33 Million	-21,665 Reduced 62.24%	13,145 $1.4 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $2.83 Million - $3.22 Million	-29,702 Reduced 46.04%	34,810 $3.37 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $1.05 Million - $1.15 Million	-11,348 Reduced 14.96%	64,512 $6.51 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $390,761 - $433,661	-4,125 Reduced 5.16%	75,860 $7.73 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $20,724 - $23,499	224 Added 0.28%	79,985 $8.07 Million
Q1 2023 May 10, 2023	BUY	$80.03 - $92.81 $157,018 - $182,093	1,962 Added 2.52%	79,761 $7.34 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $5,666 - $6,939	75 Added 0.1%	77,799 $7.06 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $504,363 - $589,877	-6,760 Reduced 8.0%	77,724 $5.91 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $159,027 - $185,156	-1,975 Reduced 2.28%	84,484 $7.14 Million
Q1 2022 May 17, 2022	SELL	$80.11 - $90.62 $249,142 - $281,828	-3,110 Reduced 3.47%	86,459 $7.59 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $273,610 - $302,550	-3,433 Reduced 3.69%	89,569 $7.83 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $129,212 - $150,321	-1,580 Reduced 1.67%	93,002 $7.61 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $290,242 - $320,580	-3,405 Reduced 3.47%	94,582 $8.63 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $51,018 - $60,165	-611 Reduced 0.62%	97,987 $8.38 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $780 - $944	10 Added 0.01%	98,598 $9.31 Million
Q3 2020 Oct 28, 2020	SELL	$82.14 - $91.0 $17,906 - $19,838	-218 Reduced 0.22%	98,588 $8.57 Million
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $32,210 - $36,257	-398 Reduced 0.4%	98,806 $8.63 Million
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $70 - $99	1 Added 0.0%	99,204 $8.18 Million
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $64,949 - $73,434	-770 Reduced 0.77%	99,203 $9.39 Million
Q3 2019 Nov 06, 2019	BUY	$85.54 - $94.26 $176,640 - $194,646	2,065 Added 2.11%	99,973 $8.69 Million
Q2 2019 Jul 24, 2019	BUY	$75.4 - $92.8 $222,203 - $273,481	2,947 Added 3.1%	97,908 $8.94 Million
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $4,895 - $5,599	65 Added 0.07%	94,961 $9.13 Million
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $85,887 - $95,635	-1,166 Reduced 1.21%	94,896 $8.14 Million
Q3 2018 Oct 15, 2018	BUY	$66.94 - $77.43 $115,203 - $133,257	1,721 Added 1.82%	96,062 $8.28 Million
Q2 2018 Jul 30, 2018	BUY	$64.91 - $73.36 $140,789 - $159,117	2,169 Added 2.35%	94,341 $7.13 Million
Q1 2018 Apr 24, 2018	BUY	$70.39 - $84.15 $169,499 - $202,633	2,408 Added 2.68%	92,172 $7.45 Million
Q4 2017 Feb 02, 2018	BUY	$72.33 - $77.64 $1.23 Million - $1.32 Million	16,989 Added 23.34%	89,764 $7.54 Million
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $5.4 Million - $5.62 Million	72,775	72,775 $6.25 Million

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.

Account